Verve Ventures

Verve Ventures is a European startup investment platform based in Zug, Switzerland, that focuses on providing qualified and institutional investors access to high-potential ventures. Founded in 2010, the firm has invested over EUR 130 million in more than 140 startups across various sectors, including science, technology, clean energy, and digital health. It operates a fully digital platform allowing private investors to build diversified portfolios with investments starting at EUR 10,000. Verve Ventures boasts a community of 5,000 registered investors, including family offices and pension funds, and is backed by Zürcher Kantonalbank, one of Switzerland's largest banks. The firm employs a dedicated team of investment professionals who rigorously screen thousands of startups annually to select the top 1% for investment. Beyond capital, Verve Ventures supports startups with essential resources such as hiring and client introductions, facilitating their growth and success in competitive markets.

Bernardo Delarue Bizzini

Senior Investment Associate

Romeo Bütler

Investment Manager

Chris Gay-Crosier

Investment Manager

Patrick Kroneman

Venture Capitalist

Martin Lehmann

Senior Investment Associate

Wassim Matar

Managing Partner

Thomas Meier

Principal

Xavier Mesnier Ph.D

Principal

Julien Pache

Venture Partner

Emma Schepers

Senior Investment Associate

Susanne Schorsch

Investment Manager

Alexander Seel

General Manager - Constructive Venture Fund

Lukas Weber

Co-Founder, CEO and Board Member

Past deals in Switzerland

Axelera AI

Series B in 2024
Axelera AI focuses on providing specialized hardware and software platforms to enhance artificial intelligence tasks, particularly in edge computing. Its primary product, the Metis™ AI Platform, combines hardware and software to offer high-performance, energy-efficient AI inference solutions. The platform's innovative design has earned recognition as a CES® 2024 Innovation Awards Honoree. Established in 2021 after incubation by Bitfury and collaboration with imec, Axelera AI is headquartered in the AI Innovation Center at the High Tech Campus in Eindhoven, with research and development offices in Belgium, Switzerland, and Italy. The company's team comprises experts in AI from leading firms and Fortune 500 companies, focusing on delivering sustainable edge applications through a custom dataflow architecture and multicore in-memory computing that minimizes power consumption.

Bcomp

Series C in 2024
Bcomp Ltd. is a manufacturer based in Fribourg, Switzerland, specializing in natural fiber composites. Founded in 2003, the company produces innovative products such as ampliTex, a natural flax fiber available in various forms, bCores, a lightweight wood core, and powerRibs, a reinforcement material made from natural fibers. Bcomp's technologies, developed from years of research and patented innovations, allow for the creation of structural components that can effectively replace traditional materials like aluminum and carbon fiber. The company serves diverse industries, including sports, automotive, acoustics, aerospace, electronics, design, and leisure, focusing on enhancing efficiency in weight, rigidity, shock absorption, and damping. Bcomp collaborates closely with its customers to tailor solutions that meet specific needs while continuing to strengthen its research and development efforts through academic partnerships.

Artiria Medical

Series A in 2024
Artiria Medical SA develops innovative micro-actuated devices aimed at treating vascular diseases, particularly in the brain. Founded in 2019 and based in Lausanne, Switzerland, the company focuses on enhancing the precision and control of surgical procedures involving catheters and guidewires. Its technology facilitates micromotion within brain arteries, thereby improving navigation during stroke treatments. By enabling surgeons to perform these complex procedures with greater accuracy, Artiria Medical contributes to better patient outcomes and the potential to save lives.

Transmutex

Series A in 2024
Transmutex is a Swiss company founded in 2019 that specializes in advanced nuclear technology aimed at significantly reducing the stockpile of existing nuclear waste. The company utilizes particle accelerators to transmute long-lived nuclear waste, transforming it into less harmful materials while simultaneously generating carbon-free energy. This innovative approach offers a solution to the challenges faced by traditional nuclear power plants, allowing for scalable energy production that can either be reintegrated into the energy grid or utilized for green hydrogen production. The team at Transmutex comprises physicists, computer scientists, and environmentalists, and builds upon technologies previously tested at CERN and the Paul Scherrer Institute.

Memo Therapeutics

Series C in 2023
Memo Therapeutics AG, based in Basel, Switzerland, specializes in innovative antibody discovery and immune repertoire analysis. The company utilizes its proprietary MemoMAB platform, which generates a recombinant in vitro copy of an individual's B cell or antibody repertoire, creating extensive libraries that represent unique immune responses. These libraries are expected to contain a vast array of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics applies this technology in its own antibody lead discovery programs and partners with other entities to enhance research and development in the fields of viral infections and cancer. Through its advancements, Memo Therapeutics aims to significantly improve therapeutic options for patients.

Nagi Bioscience

Series A in 2023
Nagi Bioscience SA, based in Lausanne, Switzerland, specializes in the development and manufacturing of an innovative automated testing device that utilizes microscopic worms for substance testing in pharmaceutical, chemical, and cosmetic industries. Their flagship product, the Caenorhabditis elegans-on-chip, integrates the use of these organisms for in vivo testing with a fully automated platform for in vitro culture, treatment, and analysis. This technology facilitates comprehensive toxicity testing, drug discovery, and anthelmintic testing applications, allowing clients to evaluate biological responses observable only at the whole-organism level. Nagi Bioscience aims to transform traditional testing methodologies by introducing its unique "Organism-on-Chip" technology.

Hylomorph

Series B in 2023
Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices. The company was founded in 2014 and is headquartered in Zurich, Switzerland.

Verity

Series B in 2023
Verity Studios AG, founded in 2014 and based in Zurich, Switzerland, specializes in the development of indoor drone systems. The company is recognized as a leader in the indoor drone market, providing innovative solutions for both the live event and logistics industries. Verity offers end-to-end drone show production services that cater to bespoke events, theatrical productions, and entertainment shows, delivering captivating aerial performances for clients such as Cirque du Soleil and Madison Square Garden. Additionally, Verity has created a commercially successful inventory tracking solution using fully autonomous indoor drones, which is deployed in warehouses to enhance operational efficiency, reduce costs, and minimize errors. Its clientele includes prominent companies like Maersk and Samsung SDS. With a commitment to sustainability, Verity’s systems also aim to lower waste and carbon emissions.

Axelera AI

Series A in 2023
Axelera AI focuses on providing specialized hardware and software platforms to enhance artificial intelligence tasks, particularly in edge computing. Its primary product, the Metis™ AI Platform, combines hardware and software to offer high-performance, energy-efficient AI inference solutions. The platform's innovative design has earned recognition as a CES® 2024 Innovation Awards Honoree. Established in 2021 after incubation by Bitfury and collaboration with imec, Axelera AI is headquartered in the AI Innovation Center at the High Tech Campus in Eindhoven, with research and development offices in Belgium, Switzerland, and Italy. The company's team comprises experts in AI from leading firms and Fortune 500 companies, focusing on delivering sustainable edge applications through a custom dataflow architecture and multicore in-memory computing that minimizes power consumption.

ANYbotics

Series B in 2023
ANYbotics AG is a Swiss robotics company founded in 2016 and based in Zurich. The company specializes in developing autonomous legged robots designed for industrial applications, particularly in hazardous and complex environments. These robots feature advanced capabilities such as docking stations, robust waterproof designs, and various sensing technologies. They are equipped to perform tasks like asset monitoring, equipment health checks, and event detection, thereby enhancing productivity and safety for workers in sectors such as oil and gas, power, energy, mining, chemicals, transportation, and construction. With a team of over 100 employees, ANYbotics aims to support industrial facilities in their inspection needs, promoting more sustainable operations through intelligent robotic solutions.

EcoRobotix

Series B in 2023
EcoRobotix Ltd is a Swiss company that specializes in the development and manufacture of autonomous farming machines designed for efficient weeding of row crops, meadows, and intercropping cultures. Founded in 2011 and based in Yverdon-les-Bains, the company offers an innovative product known as ARA, which employs advanced AI for plant recognition and ultra-high precision spraying. This technology allows the machine to detect weeds and apply a micro dose of herbicide directly to them, significantly reducing chemical usage by 70-95%. By utilizing a combination of camera systems, GPS RTK, and sensors, EcoRobotix enables farmers to minimize their environmental impact while lowering operational costs and enhancing crop yields.

Wingtra

Series B in 2023
Wingtra AG, founded in 2014 and based in Zürich, Switzerland, specializes in the manufacture of professional drones, notably the WingtraOne, a vertical take-off and landing (VTOL) UAV. This drone is designed for high-precision data collection and has applications across various industries, including surveying, agriculture, forestry, and infrastructure management. Since its market introduction in 2017, Wingtra has established partnerships with over 50 major surveying equipment dealers globally, facilitating the adoption of its technology. The WingtraOne can be operated using WingtraPilot software, enabling users to collect survey-grade aerial data that can be transformed into two-dimensional maps and three-dimensional models, thereby enhancing monitoring and inspection capabilities in sectors such as construction, mining, and environmental management.

Flyability

Series C in 2023
Flyability SA is a Swiss company founded in 2014 and based in Lausanne, specializing in the development and manufacturing of flying robots designed for industrial inspections in inaccessible and confined spaces. The company’s flagship product, Elios, is a collision-tolerant flying robot that allows for safe inspections in complex environments, such as within buildings and urban areas, reducing the need for human presence in hazardous situations. Flyability’s technology addresses critical issues in the rapidly growing drone industry, particularly concerning collision and injury risks. Its applications extend beyond industrial inspections to include search and rescue operations and security assessments, enabling professionals to gather vital data while ensuring safety. The company has received numerous accolades, including the Drones for Good Award, reflecting its commitment to innovation and societal impact.

Flyability

Series C in 2022
Flyability SA is a Swiss company founded in 2014 and based in Lausanne, specializing in the development and manufacturing of flying robots designed for industrial inspections in inaccessible and confined spaces. The company’s flagship product, Elios, is a collision-tolerant flying robot that allows for safe inspections in complex environments, such as within buildings and urban areas, reducing the need for human presence in hazardous situations. Flyability’s technology addresses critical issues in the rapidly growing drone industry, particularly concerning collision and injury risks. Its applications extend beyond industrial inspections to include search and rescue operations and security assessments, enabling professionals to gather vital data while ensuring safety. The company has received numerous accolades, including the Drones for Good Award, reflecting its commitment to innovation and societal impact.

Invasight

Seed Round in 2022
Invasight is a clinical biotech company based in Zurich, Switzerland, founded in 2019. The company specializes in advancing cell invasion research with the aim of accelerating the development of targeted therapies for invasive cancers. By focusing on the proteins involved in cancer cell invasion, Invasight aims to create therapies that minimize the side effects typically associated with conventional cancer treatments. This innovative approach seeks to provide cancer patients with effective and safe treatment options tailored to their specific needs.

holo|one

Series A in 2022
holo|one is a software company developing “sphere” – the award-winning, standardized Mixed Reality (MR) platform solution. It hails from Switzerland, with offices in Zurich, the Bay Area, and Chongqing, China.

Sleepiz

Series A in 2022
Sleepiz AG, based in Zurich, Switzerland, specializes in manufacturing a non-contact sleep monitoring device aimed at enhancing healthcare accessibility in home environments. Incorporated in 2018, the company's innovative product is designed to be placed on a bedside table, where it accurately measures patients' breathing patterns, heart rate, and body movements using advanced wireless millimeter wave technology and artificial intelligence. This device not only facilitates the diagnosis of sleep disorders but also enables long-term monitoring of chronic diseases, allowing healthcare providers to track patient progression and implement timely interventions for improved treatment outcomes. Through its user-friendly and precise approach, Sleepiz is positioned to significantly contribute to patient-centric disease management.

9T Labs

Series A in 2022
9T Labs AG, founded in 2018 and based in Zürich, Switzerland, specializes in manufacturing 3D printers that produce carbon composite parts. The company integrates advanced software, additive manufacturing, and industry-standard materials to offer a digital composite production solution. Utilizing its proprietary Additive Fusion Technology (AFT), 9T Labs enables manufacturers to create lightweight structural components with precise 3D fiber orientation, facilitating mass production at reduced costs. The intuitive design software supports optimal fiber placement, while automated production equipment enhances efficiency across the entire value chain. The technology allows for the efficient production of high-performance parts, including applications in drones and prosthetics, making it accessible for engineers and manufacturers alike.

Memo Therapeutics

Series B in 2022
Memo Therapeutics AG, based in Basel, Switzerland, specializes in innovative antibody discovery and immune repertoire analysis. The company utilizes its proprietary MemoMAB platform, which generates a recombinant in vitro copy of an individual's B cell or antibody repertoire, creating extensive libraries that represent unique immune responses. These libraries are expected to contain a vast array of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics applies this technology in its own antibody lead discovery programs and partners with other entities to enhance research and development in the fields of viral infections and cancer. Through its advancements, Memo Therapeutics aims to significantly improve therapeutic options for patients.

Nanoleq

Series A in 2021
Nanoleq AG, established in 2017 and based in Zurich, Switzerland, specializes in the development and manufacturing of innovative electric cables using stretchable electronics. As a spinoff from ETH Zurich, the company focuses on integrating electronic functionalities into textiles, particularly for health monitoring. Its products utilize advanced conductive silicone technology to create soft sensors capable of recording vital signs such as heartbeat, electrocardiograms, and breathing patterns through comfortable and washable garments. These sensors are designed for various applications, including healthcare, sports, and workwear, with the aim of setting a standard in the health-monitoring textile market. Nanoleq is committed to facilitating the rapid development and widespread adoption of smart textiles across multiple sectors, including robotics and aerospace.

Hylomorph

Series B in 2021
Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices. The company was founded in 2014 and is headquartered in Zurich, Switzerland.

Seervision

Funding Round in 2021
Seervision AG, a Swiss startup founded in 2016 and based in Zurich, specializes in developing innovative software for camera automation aimed at enhancing video production efficiency. Originally conceived at ETH Zurich to improve live lecture recordings, the company has evolved into a dynamic enterprise with over 30 employees. The Seervision Suite now automates workflows primarily for corporate studios, stage events, and educational spaces. By leveraging advanced video analysis algorithms and technologies such as motion control, computer vision, and machine learning, Seervision enables fully automated productions, including autonomous camera tracking and facial recognition. This integration simplifies live production workflows, making it easier for users to manage hybrid meeting experiences and other video production needs.

Scewo

Series A in 2021
Scewo AG, founded in 2017 and headquartered in Winterthur, Switzerland, specializes in designing and manufacturing innovative electric wheelchairs tailored for individuals with mobility impairments. The company has developed a unique stair-climbing wheelchair that integrates both wheels and tracks, allowing for enhanced maneuverability over various terrains, including curbs, tram tracks, grass, and uneven surfaces. This self-balancing wheelchair features an active control system that maintains stability and levelness, enabling users to navigate obstacles with ease. Users can control the chair through a joystick or by shifting their body weight, providing a versatile solution to improve mobility and independence for those with disabilities.

Sleepiz

Series A in 2021
Sleepiz AG, based in Zurich, Switzerland, specializes in manufacturing a non-contact sleep monitoring device aimed at enhancing healthcare accessibility in home environments. Incorporated in 2018, the company's innovative product is designed to be placed on a bedside table, where it accurately measures patients' breathing patterns, heart rate, and body movements using advanced wireless millimeter wave technology and artificial intelligence. This device not only facilitates the diagnosis of sleep disorders but also enables long-term monitoring of chronic diseases, allowing healthcare providers to track patient progression and implement timely interventions for improved treatment outcomes. Through its user-friendly and precise approach, Sleepiz is positioned to significantly contribute to patient-centric disease management.

EcoRobotix

Venture Round in 2021
EcoRobotix Ltd is a Swiss company that specializes in the development and manufacture of autonomous farming machines designed for efficient weeding of row crops, meadows, and intercropping cultures. Founded in 2011 and based in Yverdon-les-Bains, the company offers an innovative product known as ARA, which employs advanced AI for plant recognition and ultra-high precision spraying. This technology allows the machine to detect weeds and apply a micro dose of herbicide directly to them, significantly reducing chemical usage by 70-95%. By utilizing a combination of camera systems, GPS RTK, and sensors, EcoRobotix enables farmers to minimize their environmental impact while lowering operational costs and enhancing crop yields.

Qnami

Series A in 2021
Qnami AG is a Swiss company established in 2017, specializing in the development of quantum sensing technologies for nanoscale imaging. The company manufactures non-invasive sensors, including the ProteusQ magnetic imaging microscope and the Quantum Diamond product line, which features diamond probes with single nitrogen-vacancy (NV) centers for high-resolution magnetic imaging. These advanced technologies enable the measurement of electric and magnetic fields with exceptional sensitivity, facilitating a range of applications such as the characterization of magnetic random-access memory (MRAM), imaging of proteins, and fundamental studies of superconductors. Qnami's innovations unlock new possibilities in both scientific research and industrial applications, aiming to enhance understanding and improve various aspects of life and technology.

NetGuardians

Series D in 2020
NetGuardians SA is a software company that specializes in fraud prevention and risk mitigation solutions for the banking and financial services sectors. Founded in 2007 and based in Yverdon-les-Bains, Switzerland, with additional offices in Nairobi, Warsaw, and Singapore, the company utilizes big data and behavioral analytics to address various fraud challenges, including mobile banking and identity theft. Its key offerings include FraudGuardian, which provides predefined controls for continuous auditing of user behavior across multiple channels, and RiskGuardian, an automation tool for compliance that features regulatory templates, automated updates, and reporting capabilities. NetGuardians serves a diverse clientele, including CIOs, CISOs, internal auditors, and compliance professionals, primarily in Europe, the Middle East, Asia, and Africa, and distributes its products through resellers.

Guuru

Series A in 2020
Guuru Ltd. is a Swiss company that specializes in developing a cloud-based platform designed to connect clients with experts across various fields. Founded in 2015 and headquartered in Zurich, Guuru offers an intermediary service that facilitates consultancy through a live chat tool, allowing clients to pose questions and receive real-time answers from knowledgeable professionals. The platform enhances customer experiences by enabling interactions between potential customers and brand ambassadors, who provide insights and share their experiences regarding specific products. This approach not only helps businesses respond more swiftly to customer inquiries but also accelerates the purchasing decision process by fostering meaningful exchanges that build authentic connections between brands and consumers.

Verity

Convertible Note in 2020
Verity Studios AG, founded in 2014 and based in Zurich, Switzerland, specializes in the development of indoor drone systems. The company is recognized as a leader in the indoor drone market, providing innovative solutions for both the live event and logistics industries. Verity offers end-to-end drone show production services that cater to bespoke events, theatrical productions, and entertainment shows, delivering captivating aerial performances for clients such as Cirque du Soleil and Madison Square Garden. Additionally, Verity has created a commercially successful inventory tracking solution using fully autonomous indoor drones, which is deployed in warehouses to enhance operational efficiency, reduce costs, and minimize errors. Its clientele includes prominent companies like Maersk and Samsung SDS. With a commitment to sustainability, Verity’s systems also aim to lower waste and carbon emissions.

Memo Therapeutics

Series B in 2020
Memo Therapeutics AG, based in Basel, Switzerland, specializes in innovative antibody discovery and immune repertoire analysis. The company utilizes its proprietary MemoMAB platform, which generates a recombinant in vitro copy of an individual's B cell or antibody repertoire, creating extensive libraries that represent unique immune responses. These libraries are expected to contain a vast array of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics applies this technology in its own antibody lead discovery programs and partners with other entities to enhance research and development in the fields of viral infections and cancer. Through its advancements, Memo Therapeutics aims to significantly improve therapeutic options for patients.

Artiria Medical

Series A in 2020
Artiria Medical SA develops innovative micro-actuated devices aimed at treating vascular diseases, particularly in the brain. Founded in 2019 and based in Lausanne, Switzerland, the company focuses on enhancing the precision and control of surgical procedures involving catheters and guidewires. Its technology facilitates micromotion within brain arteries, thereby improving navigation during stroke treatments. By enabling surgeons to perform these complex procedures with greater accuracy, Artiria Medical contributes to better patient outcomes and the potential to save lives.

Metaco

Series A in 2020
Metaco is a Swiss company that specializes in providing institutional digital asset management solutions. It offers a comprehensive orchestration platform designed for financial institutions to issue, secure, manage, and trade digital assets. Metaco's platform supports the entire lifecycle of asset tokens, including the management of cryptocurrencies, tokens, and smart contracts. By utilizing advanced blockchain technologies, the company ensures a secure and efficient environment for digital asset management. Additionally, Metaco's solutions incorporate risk management to balance asset security and liquidity, allowing institutions to connect with over 50 exchanges, brokers, and market makers, thereby facilitating seamless trading across various asset classes such as equities, bonds, and derivatives.

Mobbot

Seed Round in 2020
Mobbot SA is a Swiss company founded in 2018, specializing in 3D concrete printing technology for the construction industry. Based in Fribourg, the company has developed a digital fabrication system that allows construction firms to produce custom-made concrete products efficiently. By integrating passive reinforcement and utilizing conventional concrete from ready-mix plants, Mobbot's technology significantly reduces production and installation costs. It enables construction companies to streamline their operations, transforming a task that traditionally takes three days into a process that can be completed in just one hour. Through its innovative approach, Mobbot aims to enhance productivity and cost-effectiveness in infrastructure development.

9T Labs

Seed Round in 2020
9T Labs AG, founded in 2018 and based in Zürich, Switzerland, specializes in manufacturing 3D printers that produce carbon composite parts. The company integrates advanced software, additive manufacturing, and industry-standard materials to offer a digital composite production solution. Utilizing its proprietary Additive Fusion Technology (AFT), 9T Labs enables manufacturers to create lightweight structural components with precise 3D fiber orientation, facilitating mass production at reduced costs. The intuitive design software supports optimal fiber placement, while automated production equipment enhances efficiency across the entire value chain. The technology allows for the efficient production of high-performance parts, including applications in drones and prosthetics, making it accessible for engineers and manufacturers alike.

Wyden

Series A in 2020
Wyden is a global leader in institutional digital asset trading technology, providing comprehensive infrastructure solutions for financial institutions. The Wyden platform encompasses the entire trade lifecycle, from pre-trade risk assessments to order generation and automated settlement. It supports seamless integration with custody, core banking, and portfolio management systems, facilitating a smooth transition between digital and traditional assets. Engineered by a team of experts in both trading systems and crypto assets, Wyden aims to meet the highest standards of institutional needs. The company operates offices in Zurich, New York, and Singapore.

Nagi Bioscience

Seed Round in 2019
Nagi Bioscience SA, based in Lausanne, Switzerland, specializes in the development and manufacturing of an innovative automated testing device that utilizes microscopic worms for substance testing in pharmaceutical, chemical, and cosmetic industries. Their flagship product, the Caenorhabditis elegans-on-chip, integrates the use of these organisms for in vivo testing with a fully automated platform for in vitro culture, treatment, and analysis. This technology facilitates comprehensive toxicity testing, drug discovery, and anthelmintic testing applications, allowing clients to evaluate biological responses observable only at the whole-organism level. Nagi Bioscience aims to transform traditional testing methodologies by introducing its unique "Organism-on-Chip" technology.

Qnami

Seed Round in 2019
Qnami AG is a Swiss company established in 2017, specializing in the development of quantum sensing technologies for nanoscale imaging. The company manufactures non-invasive sensors, including the ProteusQ magnetic imaging microscope and the Quantum Diamond product line, which features diamond probes with single nitrogen-vacancy (NV) centers for high-resolution magnetic imaging. These advanced technologies enable the measurement of electric and magnetic fields with exceptional sensitivity, facilitating a range of applications such as the characterization of magnetic random-access memory (MRAM), imaging of proteins, and fundamental studies of superconductors. Qnami's innovations unlock new possibilities in both scientific research and industrial applications, aiming to enhance understanding and improve various aspects of life and technology.

Picstars

Venture Round in 2019
Picstars AG operates an online platform that connects brands with influencers and advertisement content creators, specializing in the sponsorship of brand ambassadors, particularly athletes. Founded in 2014 and based in Zürich, Switzerland, Picstars allows companies to identify suitable talents in sports and lifestyle to promote their campaigns via social media. The platform facilitates the creation of marketing campaigns and provides tools for performance tracking, enabling brands to measure the success of their influencer partnerships effectively. By streamlining the matchmaking process between brands and influencers, Picstars enhances the efficiency of marketing strategies in the digital age.

Yonder AG

Seed Round in 2019
Yonder AG is a Swiss company, founded in 2015 and based in Zurich, that specializes in documentation-as-a-service (DaaS) solutions. The company's primary offering, Yonder Mind, is an application software designed for information management, enabling organizations to create, maintain, and deliver relevant content to users efficiently. Yonder AG also offers services related to document content creation and conversion, helping clients streamline information dissemination through shorter documents and manageable revisions.

Versantis

Series B in 2019
Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, the company is dedicated to addressing the unmet medical needs of patients globally. Its lead candidate, VS-01, is in the preclinical stage and aims to be the first drug for acute liver disease, with the unique capability of supporting multiple organ function. VS-01 has received Orphan Drug Designation for acute liver failure, highlighting its potential in treating rare conditions. Additionally, Versantis is advancing other products in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent significant opportunities for improving patient outcomes in the field of liver health and beyond.

Haelixa

Seed Round in 2019
Haelixa LLC specializes in DNA-based tracing and tagging technology aimed at enhancing supply chain transparency and integrity across various industries. Founded in 2012 and based in Zürich, Switzerland, the company offers solutions for tracking and monitoring fluids in the energy sector, including water and oil tracers that can characterize oil or geothermal reservoirs. Additionally, Haelixa provides customized solutions for groundwater tracing and product authentication, which help in identifying and preventing counterfeiting and other irregularities. Their technology can be applied to a range of products, such as textiles, gold, and diamonds, allowing clients to protect their brands by ensuring proof of authenticity from production to retail.

Seervision

Seed Round in 2019
Seervision AG, a Swiss startup founded in 2016 and based in Zurich, specializes in developing innovative software for camera automation aimed at enhancing video production efficiency. Originally conceived at ETH Zurich to improve live lecture recordings, the company has evolved into a dynamic enterprise with over 30 employees. The Seervision Suite now automates workflows primarily for corporate studios, stage events, and educational spaces. By leveraging advanced video analysis algorithms and technologies such as motion control, computer vision, and machine learning, Seervision enables fully automated productions, including autonomous camera tracking and facial recognition. This integration simplifies live production workflows, making it easier for users to manage hybrid meeting experiences and other video production needs.

ActLight

Series C in 2019
ActLight SA, founded in 2010 and based in Lausanne, Switzerland, specializes in the development of advanced photodetectors and photovoltaic energy harvesting technologies. The company is known for its Dynamic PhotoDiode (DPD) technology, which enhances the efficiency and accuracy of various light sensing applications, such as heart rate monitoring, gesture control, and optical data transfer. ActLight operates primarily in the fields of CMOS photonics, serving markets including consumer electronics, healthcare, autonomous driving, and robotics. As a fabless company, it focuses on intellectual property and offers design and technology advisory services to its clients. The company's innovative R&D efforts are bolstered by collaborations with leading institutions, allowing it to establish a strong presence in the photonics sector. ActLight generates revenue through a licensing business model, which includes license and royalty fees as well as non-recurring engineering projects. Its team comprises experts in various fields, ensuring robust support for its technologies and clients.

Wingtra

Series A in 2019
Wingtra AG, founded in 2014 and based in Zürich, Switzerland, specializes in the manufacture of professional drones, notably the WingtraOne, a vertical take-off and landing (VTOL) UAV. This drone is designed for high-precision data collection and has applications across various industries, including surveying, agriculture, forestry, and infrastructure management. Since its market introduction in 2017, Wingtra has established partnerships with over 50 major surveying equipment dealers globally, facilitating the adoption of its technology. The WingtraOne can be operated using WingtraPilot software, enabling users to collect survey-grade aerial data that can be transformed into two-dimensional maps and three-dimensional models, thereby enhancing monitoring and inspection capabilities in sectors such as construction, mining, and environmental management.

Piavita

Series A in 2019
Piavita AG, founded in 2016 and based in Zurich, Switzerland, specializes in developing a matchbox-sized wearable device that precisely measures vital data in pets and horses. Recognizing the increasing demand for high-quality veterinary care, the company addresses the challenges faced by veterinarians in diagnosing and monitoring animal health due to limited information and outdated practices. Piavita's innovative solution includes a wearable technology that tracks vital signs through an animal's coat without the need for clipping, combined with a web-based application that enables real-time monitoring and historical data access. This system enhances communication between veterinarians and pet owners, aiming to lead the digital transformation in the veterinary industry by providing reliable insights into animal health.

Guuru

Series A in 2019
Guuru Ltd. is a Swiss company that specializes in developing a cloud-based platform designed to connect clients with experts across various fields. Founded in 2015 and headquartered in Zurich, Guuru offers an intermediary service that facilitates consultancy through a live chat tool, allowing clients to pose questions and receive real-time answers from knowledgeable professionals. The platform enhances customer experiences by enabling interactions between potential customers and brand ambassadors, who provide insights and share their experiences regarding specific products. This approach not only helps businesses respond more swiftly to customer inquiries but also accelerates the purchasing decision process by fostering meaningful exchanges that build authentic connections between brands and consumers.

Wildbiene + Partner

Series B in 2019
Wildbiene + Partner focuses on promoting sustainable pollination and enhancing bee conservation efforts. The company manufactures BeeHomes, designed to provide safe habitats for harmless mason bees, which play a crucial role in pollinating wild plants and fruit trees. By improving the pollination environment, Wildbiene + Partner supports local farmers in accessing these essential pollinators during the spring season. Additionally, the organization engages in educational initiatives to raise awareness about the importance of wild bees and actively works to create suitable habitats for them. Through these efforts, Wildbiene + Partner aims to ensure the long-term survival of pollinators in Switzerland.

InterAx Biotech Ltd

Series A in 2019
InterAx Biotech Ltd is a biotechnology company based in Villigen, Switzerland, focused on developing a platform for the discovery of functionally selective drugs targeting G-Protein Coupled Receptors (GPCRs). Founded in 2016, the company integrates bioanalytical methods and computational pharmacology to assist in drug candidate design and selection. Its innovative platform combines high-throughput biochemical screening with artificial intelligence and mathematical modeling of cell signaling, facilitating the identification and optimization of drug candidates for various diseases, including those associated with orphan GPCRs. Through its advanced approach, InterAx Biotech aims to improve drug efficacy while reducing side effects, contributing to the healthcare industry's efforts to discover safer and more effective treatments.

Seervision

Seed Round in 2018
Seervision AG, a Swiss startup founded in 2016 and based in Zurich, specializes in developing innovative software for camera automation aimed at enhancing video production efficiency. Originally conceived at ETH Zurich to improve live lecture recordings, the company has evolved into a dynamic enterprise with over 30 employees. The Seervision Suite now automates workflows primarily for corporate studios, stage events, and educational spaces. By leveraging advanced video analysis algorithms and technologies such as motion control, computer vision, and machine learning, Seervision enables fully automated productions, including autonomous camera tracking and facial recognition. This integration simplifies live production workflows, making it easier for users to manage hybrid meeting experiences and other video production needs.

Luciole Medical

Series A in 2018
Luciole Medical AG is a Swiss medical technology company that specializes in the design and manufacture of brain oxygenation monitoring systems. Founded in 2017 and based in Zurich, the company has developed a platform that accurately measures the levels of oxygenated and deoxygenated hemoglobin, as well as cerebral blood flow and other critical parameters. Its product lineup includes RheoPatch, a non-invasive sensor applied to the skin to assess oxygen metabolism and blood flow; RheoSens, an implantable probe that measures various cerebral metrics; RheoLity, which offers software for data display, analysis, and patient management; and RheoControl, which connects to medical monitors for data visualization. Luciole Medical's systems enable healthcare professionals to monitor cerebral oxygenation effectively, providing crucial insights into the patient's brain health.

Hylomorph

Series A in 2018
Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices. The company was founded in 2014 and is headquartered in Zurich, Switzerland.

TestingTime

Series A in 2018
TestingTime AG, founded in 2014 and based in Zurich, Switzerland, specializes in online recruitment services for test users, catering primarily to the UX and market research sectors. The company offers a diverse pool of over 350,000 participants, enabling clients to efficiently source individuals for usability tests, interviews, focus groups, and surveys in multiple languages, including German, French, Italian, Romansh, and English. By employing screening processes, predictive machine learning algorithms, and a smart rating system, TestingTime ensures the recruitment of high-quality test users with a low no-show rate. Its services are utilized by notable corporations such as UBS, Zalando, Microsoft, and Accenture, facilitating seamless research processes for their clients.

EcoRobotix

Series A in 2018
EcoRobotix Ltd is a Swiss company that specializes in the development and manufacture of autonomous farming machines designed for efficient weeding of row crops, meadows, and intercropping cultures. Founded in 2011 and based in Yverdon-les-Bains, the company offers an innovative product known as ARA, which employs advanced AI for plant recognition and ultra-high precision spraying. This technology allows the machine to detect weeds and apply a micro dose of herbicide directly to them, significantly reducing chemical usage by 70-95%. By utilizing a combination of camera systems, GPS RTK, and sensors, EcoRobotix enables farmers to minimize their environmental impact while lowering operational costs and enhancing crop yields.

GotCourts

Seed Round in 2018
GotCourts Ltd is a Zurich-based company that develops a software as a service (SaaS) platform dedicated to racquet sports. Founded in 2014, the platform serves as an online community for players, coaches, and court facility operators. It offers various services, including an online booking system for courts and coaches, a social network for connecting players, and tools for finding opponents and tracking progress. GotCourts aims to create the largest global hub for tennis and other racquet sports, facilitating interactions among enthusiasts and enhancing their sporting experience.

Memo Therapeutics

Series A in 2018
Memo Therapeutics AG, based in Basel, Switzerland, specializes in innovative antibody discovery and immune repertoire analysis. The company utilizes its proprietary MemoMAB platform, which generates a recombinant in vitro copy of an individual's B cell or antibody repertoire, creating extensive libraries that represent unique immune responses. These libraries are expected to contain a vast array of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics applies this technology in its own antibody lead discovery programs and partners with other entities to enhance research and development in the fields of viral infections and cancer. Through its advancements, Memo Therapeutics aims to significantly improve therapeutic options for patients.

Arviem

Series B in 2018
Arviem AG provides comprehensive global trade monitoring and management services, focusing on cargo security and supply chain visibility. With a fully managed cargo security solution, the company offers in-transit monitoring for shipments across land, sea, and air, ensuring clients receive independent and reliable data on the location and condition of their cargo. Arviem's services encompass trade monitoring, analytics, and operations support, along with advisory services such as business consulting, system integration, and compliance. The company serves various sectors, including consumer products, pharmaceuticals, chemicals, and logistics, catering to importers, exporters, and logistics service providers in Europe, Asia, and the Americas. Arviem has established strategic partnerships with several technology firms to enhance its service offerings and optimize supply chain operations for its clients. Based in Rotkreuz, Switzerland, Arviem is dedicated to enabling real-time, data-driven decision-making for businesses engaged in global trade.

Abionic

Series C in 2018
Abionic SA is a Swiss company specializing in nanotechnology-based diagnostic solutions aimed at enhancing medical diagnosis. Founded in 2010 as a spin-off from the Swiss Federal Institute of Technology Lausanne (EPFL), Abionic has developed the abioSCOPE platform, which enables rapid testing of patients' allergy profiles using just a single drop of blood. This innovative platform includes a reader for nanofluidic sensors and a smartphone application, facilitating both clinical laboratory use and point-of-care testing. Abionic's products are designed to assist healthcare professionals in diagnosing and screening various medical conditions, particularly in the realms of allergy and sepsis. The company is ISO 9001/13485 certified, demonstrating its commitment to quality management in the development and commercialization of in vitro diagnostic devices. With strategic support from various Swiss institutions, Abionic aims to become a significant player in personalized medicine on an international scale. The company is headquartered in Lausanne, Switzerland.

Medyria

Series B in 2018
Medyria AG is a Swiss medtech company based in Winterthur, specializing in sensor-based catheter navigation and sensing systems for cardiovascular procedures. Founded in 2012, the company offers a range of innovative products, including a catheter positioning system designed for X-ray and C-dye free minimally invasive interventions, as well as Flowcath, which measures blood flow. Their Trackcath technology processes flow data to enhance catheter tracking, while their OEM flow sensor utilizes proprietary technology for measuring blood and physiological fluid flow. Medyria aims to enhance the safety and effectiveness of endovascular procedures, ultimately improving patient outcomes and reducing procedural complications and costs.

Picstars

Series A in 2018
Picstars AG operates an online platform that connects brands with influencers and advertisement content creators, specializing in the sponsorship of brand ambassadors, particularly athletes. Founded in 2014 and based in Zürich, Switzerland, Picstars allows companies to identify suitable talents in sports and lifestyle to promote their campaigns via social media. The platform facilitates the creation of marketing campaigns and provides tools for performance tracking, enabling brands to measure the success of their influencer partnerships effectively. By streamlining the matchmaking process between brands and influencers, Picstars enhances the efficiency of marketing strategies in the digital age.

KiWi

Seed Round in 2018
KiWi provides micro-merchants with access to appropriate digital technology, thereby contributing to a fair and competitive market. Merchants can use their KiWi app to accept card and mobile payments, gain access to microcredit, and earn more money by selling additional KiWi services and products. KiWi was founded in 2014 and has offices in Switzerland and Mexico.

CleanGreens Solutions SA

Series A in 2017
CleanGreens Solutions SA is an agricultural technology company based in Molondin, Switzerland, focused on innovative methods for growing fresh lettuce. Established in 2012, the company utilizes mobile aeroponics, which significantly reduces water consumption and minimizes contamination risks. By integrating advancements in logistics, agronomy, climate control, and automation, CleanGreens Solutions aims to achieve up to 70 times the productivity compared to traditional farming methods. This approach not only enhances the quality and longevity of the lettuce but also ensures that customers receive fresh and pesticide-free produce. Through its commitment to sustainability and efficiency, CleanGreens Solutions is transforming the supply chain for fresh greens.

ActLight

Series B in 2017
ActLight SA, founded in 2010 and based in Lausanne, Switzerland, specializes in the development of advanced photodetectors and photovoltaic energy harvesting technologies. The company is known for its Dynamic PhotoDiode (DPD) technology, which enhances the efficiency and accuracy of various light sensing applications, such as heart rate monitoring, gesture control, and optical data transfer. ActLight operates primarily in the fields of CMOS photonics, serving markets including consumer electronics, healthcare, autonomous driving, and robotics. As a fabless company, it focuses on intellectual property and offers design and technology advisory services to its clients. The company's innovative R&D efforts are bolstered by collaborations with leading institutions, allowing it to establish a strong presence in the photonics sector. ActLight generates revenue through a licensing business model, which includes license and royalty fees as well as non-recurring engineering projects. Its team comprises experts in various fields, ensuring robust support for its technologies and clients.

DBS System

Series A in 2017
DBS System is a Swiss medtech company specializing in innovative blood collection devices, particularly the HemaXis™ platform. This advanced technology facilitates less invasive and more efficient blood sample collection and preparation, utilizing patented microfluidic technology for plasma and serum extraction with precise volume control. The HemaXis platform aims to enhance the bioanalysis potential of dried blood spot samples, promoting safer and cost-effective practices in medical testing. By streamlining blood collection, DBS System supports the integration of laboratory capabilities into personal health monitoring, ultimately contributing to the advancement of personalized medicine and big data initiatives. The company operates within the Swiss Health Valley, driving innovation in the healthcare sector.

EcoRobotix

Seed Round in 2016
EcoRobotix Ltd is a Swiss company that specializes in the development and manufacture of autonomous farming machines designed for efficient weeding of row crops, meadows, and intercropping cultures. Founded in 2011 and based in Yverdon-les-Bains, the company offers an innovative product known as ARA, which employs advanced AI for plant recognition and ultra-high precision spraying. This technology allows the machine to detect weeds and apply a micro dose of herbicide directly to them, significantly reducing chemical usage by 70-95%. By utilizing a combination of camera systems, GPS RTK, and sensors, EcoRobotix enables farmers to minimize their environmental impact while lowering operational costs and enhancing crop yields.

Lunchgate

Venture Round in 2016
Lunchgate is a restaurant rediscovery and reservation platform based in Zurich, Switzerland. It allows customers to explore restaurant interiors through 360-degree views, browse menus, and make table reservations. By providing a comprehensive online search platform, Lunchgate facilitates the discovery of dining options in and around Zurich, catering to both modern restaurants and hotels.

DomoHealth

Series A in 2016
Domo Health is a Swiss company transforming healthcare through its innovative digital health platform that connects patients to their local care environment. Powered by real-world data and AI, we enhance personalized and preventive care at home. With our SaaS clinical platform, domo.health, we monitor patients' conditions, offer safety solutions, and empower professionals to make informed decisions. Together, we're shaping a future focused on safer and healthier in-home experiences.

OrbiWise

Angel Round in 2016
OrbiWise is a Swiss company specializing in advanced technologies for the Internet of Things (IoT) industry, with a focus on developing a carrier-grade network server known as OrbiWAN, which is built on LoRa technology. This server enhances the performance of IoT services by providing real-time device messaging and targeted device group profiling, capable of supporting both single and multiple gateway access points across various environments, such as smart cities, rural areas, and industrial settings. OrbiWise's solutions aim to improve efficiency in agriculture and manufacturing, facilitate city parking, and enhance employee health and security. The company's team possesses a strong engineering background, with expertise in areas such as cloud and embedded software, communication systems, and RF/HW design. OrbiWise is committed to customer success and values honesty and innovation in its operations.

Planet Intus

Series A in 2016
Planet Intus SA specializes in the design and development of indoor geolocation software, providing infrastructure that supports both active and passive geolocation services. Founded in 2014 and headquartered in Carouge, Switzerland, the company offers a range of applications for end users, including indoor guidance, safety services, and comfort services. Its software aims to enhance user experiences in various sectors such as retail, leisure, healthcare, and security. Additionally, Planet Intus delivers analytics and insights to help professionals improve marketing strategies and operational efficiency. The team consists of skilled engineers and technicians with expertise in Geographic Information Systems, indoor positioning technologies, and mobile app development, combining French telecommunication know-how with Swiss quality standards to deliver innovative solutions.

Piavita

Seed Round in 2016
Piavita AG, founded in 2016 and based in Zurich, Switzerland, specializes in developing a matchbox-sized wearable device that precisely measures vital data in pets and horses. Recognizing the increasing demand for high-quality veterinary care, the company addresses the challenges faced by veterinarians in diagnosing and monitoring animal health due to limited information and outdated practices. Piavita's innovative solution includes a wearable technology that tracks vital signs through an animal's coat without the need for clipping, combined with a web-based application that enables real-time monitoring and historical data access. This system enhances communication between veterinarians and pet owners, aiming to lead the digital transformation in the veterinary industry by providing reliable insights into animal health.

DomoHealth

Seed Round in 2016
Domo Health is a Swiss company transforming healthcare through its innovative digital health platform that connects patients to their local care environment. Powered by real-world data and AI, we enhance personalized and preventive care at home. With our SaaS clinical platform, domo.health, we monitor patients' conditions, offer safety solutions, and empower professionals to make informed decisions. Together, we're shaping a future focused on safer and healthier in-home experiences.

TestingTime

Angel Round in 2015
TestingTime AG, founded in 2014 and based in Zurich, Switzerland, specializes in online recruitment services for test users, catering primarily to the UX and market research sectors. The company offers a diverse pool of over 350,000 participants, enabling clients to efficiently source individuals for usability tests, interviews, focus groups, and surveys in multiple languages, including German, French, Italian, Romansh, and English. By employing screening processes, predictive machine learning algorithms, and a smart rating system, TestingTime ensures the recruitment of high-quality test users with a low no-show rate. Its services are utilized by notable corporations such as UBS, Zalando, Microsoft, and Accenture, facilitating seamless research processes for their clients.

iMusician

Venture Round in 2015
iMusician Digital AG is a Swiss-based online platform established in 2007 that provides musicians with comprehensive tools to sell, manage, and monetize their music. The platform simplifies the digital music distribution process, allowing artists to sell and stream their music across major applications while maintaining control over their copyrights. iMusician enables users to track sales in real-time, ensuring they can effectively manage their earnings and protect their intellectual property. With a small, dedicated international team passionate about music, the company focuses on supporting artists so they can prioritize their creative work.

ActLight

Series A in 2015
ActLight SA, founded in 2010 and based in Lausanne, Switzerland, specializes in the development of advanced photodetectors and photovoltaic energy harvesting technologies. The company is known for its Dynamic PhotoDiode (DPD) technology, which enhances the efficiency and accuracy of various light sensing applications, such as heart rate monitoring, gesture control, and optical data transfer. ActLight operates primarily in the fields of CMOS photonics, serving markets including consumer electronics, healthcare, autonomous driving, and robotics. As a fabless company, it focuses on intellectual property and offers design and technology advisory services to its clients. The company's innovative R&D efforts are bolstered by collaborations with leading institutions, allowing it to establish a strong presence in the photonics sector. ActLight generates revenue through a licensing business model, which includes license and royalty fees as well as non-recurring engineering projects. Its team comprises experts in various fields, ensuring robust support for its technologies and clients.

Medyria

Series A in 2015
Medyria AG is a Swiss medtech company based in Winterthur, specializing in sensor-based catheter navigation and sensing systems for cardiovascular procedures. Founded in 2012, the company offers a range of innovative products, including a catheter positioning system designed for X-ray and C-dye free minimally invasive interventions, as well as Flowcath, which measures blood flow. Their Trackcath technology processes flow data to enhance catheter tracking, while their OEM flow sensor utilizes proprietary technology for measuring blood and physiological fluid flow. Medyria aims to enhance the safety and effectiveness of endovascular procedures, ultimately improving patient outcomes and reducing procedural complications and costs.

Bluetector

Series A in 2015
Bluetector AG, founded in 2012 and based in Root, Switzerland, specializes in manufacturing wastewater treatment machinery, particularly focused on the treatment of manure and biogas digestate. The company offers innovative containerized filtering systems that biologically purify wastewater, providing a cost-effective alternative to traditional disposal methods. By converting excess manure into clean water, Bluetector addresses the challenges faced by farmers who often have too much manure and insufficient land for spreading. This technology significantly reduces transportation costs associated with manure disposal, enabling farmers to manage their waste sustainably and economically. Additionally, Bluetector constructs and renovates municipal wastewater treatment plants, further contributing to effective wastewater management solutions.

Tecuro

Angel Round in 2014
Tecuro is a Switzerland-based start-up focused on addressing common issues in urology, particularly urinary tract infections (UTIs). Headquartered in Gerliswil, Luzern, the company has developed an innovative technology platform that provides antimicrobial properties while remaining gentle on the skin. This advancement is especially significant for women's urology, as it offers a means to prevent recurring UTIs through a non-invasive external application, with no known side effects. The company's flagship product, the U-med Pad, is designed for the prevention of urinary tract diseases and is close to market readiness. Tecuro's technology is protected by patents, ensuring a competitive edge and paving the way for future products targeting UTIs and uro-vaginal infections. By introducing this new technology, Tecuro also contributes to the fight against growing antibiotic resistance. The company has successfully completed the necessary steps for scalable production, positioning itself for future growth in the medical technology sector.

Lunchgate

Angel Round in 2014
Lunchgate is a restaurant rediscovery and reservation platform based in Zurich, Switzerland. It allows customers to explore restaurant interiors through 360-degree views, browse menus, and make table reservations. By providing a comprehensive online search platform, Lunchgate facilitates the discovery of dining options in and around Zurich, catering to both modern restaurants and hotels.

iMusician

Series A in 2014
iMusician Digital AG is a Swiss-based online platform established in 2007 that provides musicians with comprehensive tools to sell, manage, and monetize their music. The platform simplifies the digital music distribution process, allowing artists to sell and stream their music across major applications while maintaining control over their copyrights. iMusician enables users to track sales in real-time, ensuring they can effectively manage their earnings and protect their intellectual property. With a small, dedicated international team passionate about music, the company focuses on supporting artists so they can prioritize their creative work.

CleanGreens Solutions SA

Seed Round in 2014
CleanGreens Solutions SA is an agricultural technology company based in Molondin, Switzerland, focused on innovative methods for growing fresh lettuce. Established in 2012, the company utilizes mobile aeroponics, which significantly reduces water consumption and minimizes contamination risks. By integrating advancements in logistics, agronomy, climate control, and automation, CleanGreens Solutions aims to achieve up to 70 times the productivity compared to traditional farming methods. This approach not only enhances the quality and longevity of the lettuce but also ensures that customers receive fresh and pesticide-free produce. Through its commitment to sustainability and efficiency, CleanGreens Solutions is transforming the supply chain for fresh greens.

Naviswiss

Series A in 2013
Naviswiss develops and commercializes handheld, miniaturized surgical measuring, tracking, and navigation systems. The company’s products include CLIPON, a 3D measurement, and navigation system; LOCAS, a handheld measurement, and navigation system; and NAVITAGS, a marker used to measure the position of the item in space. Its products are primarily used for orthopedic replacement operations, such as hip and knee replacements. Naviswiss provides miniaturized surgical navigation for orthopedic surgeons to accurately implant artificial joints. The company was founded in 2007 and is based in Laufen, Switzerland.

Arviem

Seed Round in 2013
Arviem AG provides comprehensive global trade monitoring and management services, focusing on cargo security and supply chain visibility. With a fully managed cargo security solution, the company offers in-transit monitoring for shipments across land, sea, and air, ensuring clients receive independent and reliable data on the location and condition of their cargo. Arviem's services encompass trade monitoring, analytics, and operations support, along with advisory services such as business consulting, system integration, and compliance. The company serves various sectors, including consumer products, pharmaceuticals, chemicals, and logistics, catering to importers, exporters, and logistics service providers in Europe, Asia, and the Americas. Arviem has established strategic partnerships with several technology firms to enhance its service offerings and optimize supply chain operations for its clients. Based in Rotkreuz, Switzerland, Arviem is dedicated to enabling real-time, data-driven decision-making for businesses engaged in global trade.

Dahu

Series A in 2013
DAHU Sports is a Swiss company that manufactures ski boots for skiing, walking, hiking, and driving. Founded in 2011 by Nicolas Frey, DAHU Sports was officially launched in November 2013 with thousand pairs sold during the 1st season.

iMusician

Series A in 2013
iMusician Digital AG is a Swiss-based online platform established in 2007 that provides musicians with comprehensive tools to sell, manage, and monetize their music. The platform simplifies the digital music distribution process, allowing artists to sell and stream their music across major applications while maintaining control over their copyrights. iMusician enables users to track sales in real-time, ensuring they can effectively manage their earnings and protect their intellectual property. With a small, dedicated international team passionate about music, the company focuses on supporting artists so they can prioritize their creative work.

DomoHealth

Angel Round in 2012
Domo Health is a Swiss company transforming healthcare through its innovative digital health platform that connects patients to their local care environment. Powered by real-world data and AI, we enhance personalized and preventive care at home. With our SaaS clinical platform, domo.health, we monitor patients' conditions, offer safety solutions, and empower professionals to make informed decisions. Together, we're shaping a future focused on safer and healthier in-home experiences.

Agile Wind Power

Angel Round in 2012
Agile Wind Power AG, founded in 2010 and based in Dübendorf, Switzerland, specializes in developing technology solutions for energy production from wind. The company focuses on vertically-rotating wind turbines that enhance efficiency and profitability while reducing maintenance costs. These turbines are designed to be scalable, allowing for the creation of higher-density wind farms. Additionally, Agile Wind Power's products are engineered to minimize noise emissions and lower risks to local wildlife, such as birds and bats, making them a more environmentally friendly option for commercial power generation.

Uepaa®

Series A in 2012
Uepaa AG is the Lone Worker Safety and Peer2Peer (P2P) communication pioneer for mobile devices. After 10+ years of research, Uepaa AG has developed a revolutionary wireless P2P communication technology. Its first product - the Uepaa! Safety app - launched in 2013, successfully showcased this technology’s leadership position. This award-winning product evolved into today's industry standard for mobile-based lone worker safety protection. The daily companion for thousands of employees and field forces - working at risk or alone. Uepaa AG, founded in January 2012 by Mathias Haussmann and Dr Franck Legendre, is a Swiss ETH spin-off, headquartered in Zürich.

Nanotion

Angel Round in 2011
Nanotion AG, founded in June 2010 in Zurich, Switzerland, specializes in manufacturing analytical devices designed for the water, food, pharmaceutical, and chemical industries. The company focuses on detecting and characterizing nanoparticles in liquid media, offering both technology as a service and analytical devices to address the challenges associated with nanosized particle analysis. Founded by Dr. Christopher Latkoczy and Bartjan den Hartogh, Nanotion emerged from a technical collaboration with ETH Zurich and Eawag. The company's mission is to optimize industrial processes and mitigate risks linked to the use of nanomaterials, ensuring safer applications across various sectors. Tom Forrer, who has been with Nanotion since its inception, plays a key role in algorithm programming and software development, supporting the company's commitment to providing effective solutions for nanoparticle analysis.

Shadow Government

Angel Round in 2011
Shadow Government is a company that specializes in social gaming by leveraging the gamification of real countries, systems, and global events. Founded in 2011, with offices located in New York City and Zurich, the company develops games that create a unique blend of reality, governance, and entertainment. Their platform allows players to engage in strategic simulations that reflect real-world scenarios, fostering an interactive experience that aims to have a tangible impact. Through its innovative approach, Shadow Government is redefining the boundaries of traditional gaming by integrating elements of social and civic engagement.

Qvanteq

Seed Round in 2010
Qvanteq is a medtech startup company, developing novel bioactive stents to address and overcome the clinical adverse effects of today’s available coronary and endovascular stents. Its bioactive Qstent controls in-growth therefore reducing the risk of restenosis and thrombosis. The company was awarded with the CTI start-up label in 2012. Qvanteq was founded in 2009 and is held by private investors. The ISO 13485 certified company is based in Zürich, Switzerland. It is a spin-off company from the Swiss Federal Institute of Technology, Zurich.

Locatee

Locatee AG is a Zurich-based company that specializes in workplace analytics solutions aimed at optimizing office space utilization. Founded in 2014, Locatee offers an innovative analytics platform that measures office occupancy without the need for hardware. By leveraging data from various sources, the platform processes this information using patented technology to provide clear insights into space utilization. This empowers corporate leaders and managers to make informed decisions regarding their real estate portfolios. The solution not only highlights optimization opportunities but also helps organizations achieve cost savings and improve the overall workplace experience. Through intelligent analytics and user-friendly reporting features, Locatee addresses the challenges of modern corporate real estate.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.